AstraZeneca sues Arkansas to block drug-discount program [Reuters]
AstraZeneca PLC - American Depositary Shares (AZN)
Last astrazeneca plc - american depositary shares earnings: 2/5 04:00 pm
Check Earnings Report
US:NYSE Investor Relations:
astrazeneca.com/investor-relations.html
Company Research
Source: Reuters
a federal drug-discount program to include for-profit pharmacy chains such as CVS and Walgreens. The Anglo-Swedish drugmaker's lawsuit , opens new tab , filed in Little Rock federal court on Monday against the Arkansas insurance department, said the state measure violates provisions of the U.S. Constitution and federal patent law. State price caps on patented goods are prohibited under federal law, AstraZeneca's lawsuit said. It also said the state-mandated discounts violate the constitutional bar on unlawful government "takings" of private property. AstraZeneca did not immediately respond to a request for comment. Arkansas said it will challenge the lawsuit. Under federal law, drugmakers provide discounts to a specific list of “covered” healthcare providers that serve low-income populations under the federal 340B drug program. Participation in the program is required in order for pharma companies to receive funds from programs such as Medicare and Medicaid. For-profit chain
Show less
Read more
Impact Snapshot
Event Time:
AZN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
AZN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
AZN alerts
High impacting AstraZeneca PLC - American Depositary Shares news events
Weekly update
A roundup of the hottest topics
AZN
News
- AstraZeneca PLC (NASDAQ: AZN) had its price target raised by analysts at BMO Capital Markets from $80.00 to $82.00. They now have an "outperform" rating on the stock.MarketBeat
- Pharma Stock Roundup: MRK, SNY, AZN, NVS' Q1 Results, Pipeline & Regulatory Updates [Yahoo! Finance]Yahoo! Finance
- AstraZeneca: Strong In A Weak Market [Seeking Alpha]Seeking Alpha
- Regenerative Medicine Market Size Expected to Reach USD 154.05 Bn by 2033 [Yahoo! Finance]Yahoo! Finance
- Fusion (FUSN) to Report Q1 Earnings: Here's What to Expect [Yahoo! Finance]Yahoo! Finance
AZN
Sec Filings
- 4/25/24 - Form 6-K
- 4/11/24 - Form 6-K
- 4/11/24 - Form 6-K
- AZN's page on the SEC website